Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS‐CoV‐2 infection: A retrospective cohort study

As it has been shown that lopinavir (LPV) and hydroxychloroquine (HCQ) have in vitro activity against coronaviruses, they were used to treat COVID‐19 during the first wave of the epidemic in Lombardy, Italy. To compare the rate of clinical improvement between those who started LPV/ritonavir (LPV/r)+...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Med Virol
Main Authors: Giacomelli, Andrea, Pagani, Gabriele, Ridolfo, Anna L., Oreni, Letizia, Conti, Federico, Pezzati, Laura, Bradanini, Lucia, Casalini, Giacomo, Bassoli, Cinzia, Morena, Valentina, Passerini, Simone, Rizzardini, Giuliano, Cogliati, Chiara, Ceriani, Elisa, Colombo, Riccardo, Rusconi, Stefano, Gervasoni, Cristina, Cattaneo, Dario, Antinori, Spinello, Galli, Massimo
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7436522/
https://ncbi.nlm.nih.gov/pubmed/32776534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26407
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados